Wahl Bryan
SEC CIK 1841401 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | GC | 72.3K | — | $1.67M | 15 | 2022-11-29 | 2026-03-17 |
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.51M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-19 | 2026-03-17+ | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale | $68.36 | -12.4K | 72.3K | -15% | -$850.4K |
| D | 2026-03-17 | 2026-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | M - OptEx | — | +24.2K | 76.4K | +46% | — |
| M | 2025-03-20 | 2025-03-18+ | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale | $47.88 | -9,686 | 58.1K | -14% | -$463.8K |
| D | 2025-03-18 | 2025-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | M - OptEx | — | +19.2K | 61.4K | +46% | — |
| D | 2024-03-19 | 2024-03-18 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale+OE | $30.60 | -4,436 | 41.0K | -10% | -$135.7K |
| D | 2024-03-19 | 2024-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | M - OptEx | — | +12.0K | 45.4K | +36% | — |
| D | 2023-12-01 | 2023-11-29 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | M - OptEx | $0.00 | +23.9K | 40.3K | +146% | $0 |
| D | 2023-12-01 | 2023-11-30 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale+OE | $16.31 | -8,356 | 32.0K | -21% | -$136.3K |
| M | 2023-03-23 | 2023-03-21+ | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale | $12.55 | -1,078 | 16.8K | -6% | -$13.5K |
| M | 2023-03-21 | 2023-03-17+ | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale | $12.94 | -696 | 17.8K | -4% | -$9,004 |
| D | 2023-03-17 | 2023-03-16 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale+OE | $13.43 | -337 | 18.2K | -2% | -$4,526 |
| D | 2023-03-17 | 2023-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | M - OptEx | — | +4,790 | 18.5K | +35% | — |
| 2022-12-06 | 2022-12-02 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale | $16.90 | -1,154 | 13.7K | -8% | -$19.5K | |
| DM | 2022-12-01 | 2022-11-30+ | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | S - Sale+OE | $16.62 | -2,347 | 14.9K | -14% | -$39.0K |
| D | 2022-12-01 | 2022-11-29 | TARS | Tarsus Pharmaceuticals, Inc. | Wahl Bryan | GC | M - OptEx | $0.00 | +10.3K | 17.2K | +147% | $0 |
Purchase Sale Sale after option exercise All abbreviations